eli lilly weight loss news

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.

NBC News on MSN · 1d

Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

STAT · 6d

As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

1don MSN

Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...

How Eli Lilly Outpaces Nvidia—Here Is One Chart

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

The Australian Financial Review8d

Weight loss wars: a century on, the battle heats up

Gift 5 articles to anyone you choose each month when you subscribe. Times are good at Eli Lilly. Wall Street’s insatiable appetite for weight-loss drug stocks looks set to turn the company ...

1don MSN

Should Eli Lilly Investors Worry About This Unexpected FDA Move?

All of this means Lilly investors shouldn't panic. Even in the "worst case," Lilly's weight loss drugs have driven major revenue growth, and this is likely to continue -- whether compounders halt ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results